A new Houston-developed AI model is being used in a clinical trial for the first time, and researchers are watching for more.

The trial explores how Apple smartwatches can help tailor daily blood thinner use for patients with atrial fibrillation.

After a lucrative IPO in September, Richmond-based BioAge is seeing its biotech fortunes shift with its stock falling over 70 ...

Discover key challenges in clinical trial design and learn how the right software can significantly boost the likelihood of ...

The trial (NCT06207370) evaluates tafenoquine combined with standard treatment for babesiosis, addressing a critical unmet ...

BNT23001, a sublingual formulation of cladribine, will be tested in a pilot clinical trial in 2025 comparing it to MS ...

Theradaptive announced this week that it received FDA approval to expand its clinical trial for OsteoAdapt SP.

RevBio Receives Both FDA Approval to Expand its Clinical Trial and CMS Reimbursement for its Regenerative Bone Adhesive for ...

NeuroSigma, Inc., a Los Angeles-based bioelectronics company, announced today that the Center for Evidence-Based Psychiatry ...

City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States, whose ...

Just days before his fourth birthday, Santiago was diagnosed with B-cell acute lymphoblastic leukemia (B-ALL), the most ...

An investigation published by The BMJ today raises new concerns over the landmark clinical trial (PLATO) that was used to gain worldwide approval for the anti-platelet drug ticagrelor (Brilinta in the ...